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Wheat-based foods have been staple foods since about 10,000 years and constitute a
major source of energy, dietary fiber, and micronutrients for the world population. The
role of wheat in our diet, however, has recently been scrutinized by pseudoscientific
books and media reports promoting the overall impression that wheat consumption
makes people sick, stupid, fat, and addicted. Consequently, numerous consumers
in Western countries have started to question their dietary habits related to wheat
consumption and voluntarily decided to adopt a wheat-free diet without a medical
diagnosis of any wheat-related disorder (WRD), such as celiac disease, wheat allergy,
or non-celiac gluten sensitivity. The aim of this review is to achieve an objective judgment
of the positive aspects of wheat consumption as well as adverse effects for individuals
suffering from WRDs. The first part presents wheat constituents and their positive
nutritional value, in particular, the consumption of products from whole-grain flours. The
second part is focused on WRDs that affect predisposed individuals and can be treated
with a gluten-free or -reduced diet. Based on all available scientific knowledge, wheat
consumption is safe and healthy for the vast majority of people. There is no scientific
evidence to support that the general population would benefit from a wheat-free diet.
Keywords: allergy, baking, breeding, celiac disease, gluten, non-celiac gluten sensitivity (NCGS), nutritional value,
wheat
INTRODUCTION
Wheat is one of the major crops grown worldwide with a production of 7.34 × 108 tons on
an area of 2.14 × 106 km², which is about the size of Greenland (1). Wheat-based foods have
been staple foods since wheat was domesticated about 10,000 years ago, and they constitute
a major source of macro- and micronutrients and energy (15–20% of the required intake)
for the world population, especially in developing countries (2, 3). Many health benefits such
as favorable weight management and reductions in the risks for cardiovascular diseases and
type 2 diabetes have been shown to be associated with the consumption of wheat-based foods,
especially made of whole grains (4–6). Moreover, many non-food products for daily use contain
wheat constituents as valuable ingredients. As a result, the positive aspects of wheat were
commonly unquestioned. On the other hand, wheat-based foods are known to cause wheat-
related disorders (WRDs), such as celiac disease (CD), wheat allergy (WA), and non-celiac
gluten sensitivity (NCGS) in predisposed individuals (7). In the last decade, wheat received
an increasingly negative image due to a number of pseudoscientific books and press reports,
which recommended the avoidance of wheat consumption for the general population, not
only for those suffering from WRDs. As a consequence, increasing numbers of individuals in
Western countries decided to adopt a gluten-/wheat-free diet even without clear indications
of WRDs or medical advice. The percentages of individuals self-reporting a WRD among
the general population were 15% in Australia (8), 13% in the United Kingdom (9), 10%
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in Brazil (10), 8% in Mexico (11), 6% in the Netherlands (12),
and 3% in El Salvador (13). In light of this controversial debate,
the aims of this review are to provide an objective judgment of the
positive aspects of wheat consumption as well as adverse effects
for individuals suffering fromWRDs.
ORIGINS AND IMPORTANCE OF WHEAT
Wheat plants are grasses belonging to the monocot family
Poaceae. Cultivated wheat (Triticum spp.) consists of three
species: diploid (genome AmAm) einkorn (T. monococcum
ssp. monococcum), tetraploid (AABB) emmer (T. turgidum
ssp. dicoccum) and durum wheat (T. turgidum ssp. durum),
and hexaploid (AABBDD) common wheat (T. aestivum ssp.
aestivum) and spelt (T. aestivum ssp. spelta) (14). Using recent
advances in sequencing techniques, the International Wheat
Genome Sequencing Consortium (IWGSC) recently published
a detailed description of the total genome of common wheat
(cultivar Chinese Spring) and enabled access to 107,891 gene
sequences (15). Einkorn developed from wild einkorn 1 (T.
monococcum ssp. boeticum) and the cultivation of einkorn
started around 10,000 years ago in the Fertile Crescent. The
hybridization of a different wild einkorn (T. monococcum
ssp. urartu) with an Aegilops speltoides-related species (BB)
resulted in wild emmer (T. turgidum ssp. dicoccoides), the
ancestor for domesticated emmer. Some subspecies of wild
emmer developed free-threshing (naked) grains, known as
durum wheat. When durum wheat crossed with Aegilops tauschii
(DD), naked hexaploid common wheat evolved. Spelt most
likely emerged from hybridization between T. aestivum and T.
dicoccum (16).
Common (bread) wheat makes up about 95% of all
wheat cultivated globally, and most of the remaining 5% is
durum (pasta) wheat. Despite its ability to grow in variable
environmental conditions, the selection of qualified sites and soils
for wheat cultivation as well as suitable varieties and optimal crop
management are important factors to ensure high yields (17, 18).
With an estimated additional two billion people on the planet by
2050, food production needs to be increased despite challenges
arising from climate change (19, 20). Improved wheat plants,
resistant to frost, heat, drought, and/or salty soils, may increase
the grain yield and the area suitable for wheat production and
thus help ensure food security.
Wheat grains are dry one-seeded fruits (caryopses), in which
fruit and seed coats are tightly linked. The husk is fused to
the fruit coat in the hulled species einkorn, emmer, and spelt,
which means that the husk cannot be separated from the grain
by threshing. The grains consist of five main compartments
with different constituents and biological functions: Fruit coat
(pericarp) (4–5% of grain weight) and seed coat (testa) (≈1%)
are the outer layers and surround the whole grain. The inner
tissues (endosperm) comprise the aleurone layer (6–9%) and
the starchy endosperm (80–85%). The germ (3%) located at the
dorsal side of the caryopsis is the embryo, which includes a
storage cotyledon and the embryonic axis. Dry (moisture content
<12.5%), cool (<10◦C), and pest-free storage of wheat grains
protects against crop failure by providing a buffer to ensure
nutrition security worldwide.
THE SMILING FACE: WHEAT
CONSTITUENTS AND THEIR HEALTH
BENEFITS
The chemical composition of mature grains (water content
≈13%) varies in a relatively small range, although it is influenced
by species, variety, and growing conditions. Carbohydrates,
mainly present as starch (≈58%) and non-starch polysaccharides
(NSP) (≈13%), are predominant, followed by proteins (≈11%),
lipids (≈2%), and minerals (≈2%) (Table 1). Vitamins and
phytochemicals occur in very small amounts (<0.1%) but are
important due to their contribution to human health.
Mono-, Di-, and Oligosaccharides
Wheat grains contain only minor amounts (<0.1%) of the
monosaccharides D-glucose and D-fructose, but about 0.5–1.6%
of sucrose and 0.1–0.2% of maltose as disaccharides and 0.2–0.7%
of the trisaccharide raffinose. The predominant oligosaccharides
of wheat are 0.8–1.9% of fructans (22). Wheat fructans are of the
graminan-type and comprise three or more fructose monomers
linked via β-(2→1) and β-(2→6) glycosidic bonds and may also
contain one glucose monomer. The degree of polymerization
is 5–7 on average, but may also be below 5 or up to 17–19.
Fructans are enriched in the bran and adhering endosperm (3–
4%), but also present in the germ (≈2%) and endosperm (1–2%)
(23). As part of fermentable oligo-, di-, and monosaccharides and
polyols (FODMAPs), fructans and raffinose are metabolized by
gut microbiota in the colon and may exert positive health effects
similar to NSPs (see the Non-starch Polysaccharides section) by
acting as prebiotics (24). In addition to their stimulatory effect on
the composition and/or activity of beneficial gut bacteria, inulin-
type fructans were shown to have direct immunomodulating
and antioxidant protective effects on the gut mucosa (25, 26),
but it is still unclear whether graminan-type fructans have the
same effects as inulin-type fructans because studies with isolated
cereal fructans are still needed (27). However, FODMAPs are also
associated with intestinal complaints, as discussed below.
Starch
Starch is restricted to the endosperm, where it is present as
large lenticular granules (A-starch) and small spherical granules
(B-starch). The major carbohydrates of both granule types are
the polysaccharides amylose and amylopectin in a mass ratio
of about 25%/75%. Amylose consists of mainly linear α-(1→4)-
linked D-glucopyranose units that form a helical structure and
has molecular masses between 80,000 and 1 million. Apart from
α-(1→4) glycosidic bonds, amylopectin has a branched structure
with α-(1→6) bonds occurring every 24–30 glucose units and
reaches molecular masses as high as 100 million (28). Starch
is important for end-product quality and important for human
nutrition. It constitutes the main source of energy (11.4 kJ/g
of wholegrain wheat flour and 13.1 kJ/g of white wheat flour)
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TABLE 1 | Average contents of grain constituents of common wheat (21).
Main constituents (g/100g) Minerals (mg/100g) Vitamins (µg/100g)
Carbohydrates 73.2 Potassium 380 B3 5,100
Starch 58.2 Phosphorus 342 E 1,400
Non-starch polysaccharides 13.3 Magnesium 97 B5 1,200
Mono-, di-, oligosaccharides 1.7 Calcium 33 B1 455
Water 12.7 Sodium 7.7 B6 269
Protein 10.6 Iron 3.2 B2 94
Lipids 1.8 Manganese 3.1 B9 87
Minerals 1.7 Zinc 2.6 B7 6
because starch is readily degraded by amylases during human
gastrointestinal digestion to its glucose monomers.
Resistant starch is the proportion of starch that escapes
digestion in the upper gastrointestinal tract and small intestine
(29), resulting in a caloric value of 8 kJ/g compared to 15
kJ/g for rapidly digestible starch. It is inaccessible to amylases
depending on the size, shape, and crystallinity of the starch
granule, the complexation of amylose with lipids, proteins, and
phosphate as well as food processing (30, 31). Similar to NSP,
resistant starch forms part of dietary fiber (DF) because it is
fermented by microbiota in the colon to short-chain fatty acids.
Especially butyrate promotes normal colon function by serving as
a source of energy for the epithelial cells and by lowering luminal
pH, which, in turn, facilitates the growth, and proliferation of
beneficial gut microbiota (32, 33). Further, health benefits of
resistant starch include improved insulin sensitivity (34), reduced
oxidative stress in the colon (35), and lower body fat levels (36).
Despite the different effects discussed before, the EU register on
Nutrition and Health Claims contains only one authorized entry
asserting the reduction of post-prandial glycemic responses for
foods where resistant starch is at least 14% of total starch. Wheat
whole grain flour contains about 3% of resistant starch and thus
contributes to the estimated intake of 3–6 g/day in Europe (37).
However, this is still far from the recommended intake of 20 g of
resistant starch/day that is needed to achieve the positive health
effects (38).
Non-starch Polysaccharides
NSPs include the cell wall polysaccharides arabinoxylans (AX,
5.5–7.4%), cellulose (1.7–3.0%), and β-glucans (0.5–1.0%) (22),
but also minor contents of glucomannan, callose, xyloglucan,
and pectins. Compared to amylose and amylopectin, NSPs are
non-granular and belong to DF because human gastrointestinal
enzymes are not able to cleave the predominant β-glycosidic
linkages of the monosaccharide units. Depending on the wheat
grain tissue, the composition of NSP varies between the
endosperm, the bran, the aleurone, and the outer pericarp (39).
AX consist of a chain of β-(1→4)-linked D-xylopyranose
residues carrying substitutions via (2→1)- and/or (3→1)-
glycosidic bonds to α-L-arabinofuranose residues. Some
arabinofuranose residues may additionally be linked to ferulic
acid at C5, so that two adjacent AX chains may become
crosslinked via diferulate following oxidation. The extent of
diferulate crosslinking affects the solubility and viscosity of
AX that can be subdivided into water-extractable (WE)-AX
and water-unextractable (WU)-AX. Cellulose consists of linear
β-(1→4)-linked D-glucopyranose units, whereas β-glucans
are β-D-glucopyranose units linked via (1→3)- and (1→4)-
glycosidic bonds. Compared to oats and barley, wheat β-glucans
are poorly soluble. Wheat bran composition is significantly
influenced by genotype × environment interactions, and the
content of neutral detergent fiber ranged from 19 to 31%, that of
acid detergent fiber from 5 to 10%, that of cellulose from 3 to 9%
and that of hemicellulose from 14 to 21% (40).
All NSPs as well as lignin and fructans are summarized as DF.
Wholegrain wheat flour contains 10.3–15.5% of total DF, whereas
white flour only has 1.9–6.3% (41). Countless studies support the
beneficial effects of wheat NSP on human health, including the
comprehensive review by the UK Scientific Advisory Committee
on Nutrition (SACN) (42). The most important effects include
the regulation of colonic functions, protection against colonic
cancer, normalization of serum lipid levels, and attenuation
of post-prandial glucose response. A number of studies have
reported the protective effects of wheat DF against colon, small
intestinal, pancreatic, prostate, and breast cancer, with the effects
on colorectal cancer being most evident (43–45). The influence
of DF on the incidence of cardiovascular diseases has been
the subject of many studies, and the relation between whole-
grain intake and improved cardiovascular functions were clearly
demonstrated with reduced risks for coronary events, stroke,
elevated blood pressure, and hypertension (46). Many studies
demonstrated that DF, enriched in whole grain products, has
the ability to reduce insulin and glucose response significantly
and, thus, reduce the occurrence of type 2 diabetes (47–49).
Whether the consumption of DF-rich foods reduces appetite and
contributes to weight control needs further clinical investigations
(50). Currently, the EU Register on Nutrition and Health Claims
contains two authorized entries for wheat bran fiber, one claiming
reduced intestinal transit time and the other increased fecal bulk.
Wheat AX is listed as suitable for the reduction of post-prandial
glycemic responses. About 40 more entries related to DF were
submitted, but not authorized, mostly due to the fact that the
food constituent was not sufficiently characterized in relation to
the claimed effects and a missing cause and effect relationship.
Proteins
Together with yield, grain protein content is of primary
importance for wheat breeding because the content and
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composition of wheat proteins largely determine the bread
making quality of wheat (51). Both protein content and
composition are influenced by genetic and environmental
factors, but the interaction between the two complicates the
identification of molecular markers linked to these traits (15).
Among environmental factors, nitrogen fertilization is the
most prominent determinant linked to protein content and
composition, but other factors such as soil fertility, precipitation,
temperature, and altitude also play a role (52). The protein
content of wheat may range from 7 to 22%, but mostly lies
between 10 and 15% (53). The highest percentages of proteins
within the grain are found in the germ (34%), followed by the
aleurone (23%) and 5–6% in the outer layers. Consequently, the
protein content of whole-grain flour is usually about 2% higher
compared to white flour.
The protein fraction of wheat consists of over 100 individual
proteins, which can be classified according to their functions:
storage proteins, metabolic proteins, protective proteins, and
miscellaneous proteins with further specific functions. Gluten
proteins are storage proteins located in the endosperm (54),
representing around 80% of total grain protein and can be
grouped into monomeric gliadins soluble in aqueous alcohols
and insoluble polymeric glutenins (55, 56). Gliadins have
molecular masses between 30,000 and 55,000 and are structurally
differentiated into four types: ω5-, ω1,2-, and α- and γ-gliadins.
Glutenins are linked by interchain disulfide bonds and have
molecular masses between 600,000 and more than 10 million.
The respective monomers are classified into low-molecular-
weight (LMW) and high-molecular-weight (HMW) glutenin
subunits (GS) with molecular masses around 30,000 and 75,000,
respectively. Metabolic proteins include enzymes like hydrolases,
which cleave starch (amylases), proteins (peptidases), and lipids
(lipases), as well as other oxidoreductases, transferases, and
further enzymes (57). The majority of protective proteins are
enzyme inhibitors that inhibit external amylase and peptidase
activities, some of which are bifunctional like α-amylase/trypsin
inhibitors (ATIs). The group of miscellaneous proteins includes,
e.g., puroindolines, purothionins, and agglutinins (58, 59).
The nutritional value of wheat proteins is determined by their
relative contents of the essential amino acids valine, leucine,
isoleucine, phenylalanine/tyrosine, tryptophan, threonine,
methionine/cysteine, lysine, and the semi-essential arginine and
histidine (60). Lysine is the first limiting amino acid in wheat
grains, whereas the other essential amino acids are present in
adequate amounts (41). The biological value of white wheat
flour is estimated to be 52 and that of whole-grain wheat flour is
17–26% higher (61). This difference is due to the fact that white
flour contains higher proportions of gluten proteins compared
to whole-grain flour, and the amino acid composition of gluten
is characterized by exceptionally high contents of non-essential
glutamine (26–53%) and proline (10–29%) (62).
Lipids
Wheat lipids constitute about 2–2.5% of the flour and can be
classified into non-polar lipids (acylglycerols and free fatty
acids) and polar lipids (phospholipids and glycolipids). The
major components of non-polar lipids are triacylglycerols
(≈40% of lipids) and free fatty acids (≈15%), while the
percentages of mono- and diacylglycerols (≈1 and 4%,
respectively) and sterol lipids (<1%) are low. Wheat
phospholipids are composed of lysophosphatidylcholine
(≈2%), phosphatidylcholine (≈1%), and <1% each of
phosphatidylethanolamine, N-acylphosphatidylethanolamine,
phosphatidylglycerol, and phosphatidyl inositol. Wheat
glycolipids are comprised of digalactosyldiacylglycerol (DGDG)
(≈15%), monogalactosyldiacylglycerol (MGDG) (≈4%), as well
as DGMG and MGMG (about 1% each) (63, 64). Regarding
nutritional benefits, wheat has high amounts of oleic acid
(≈14%) as well as linoleic acid (≈60%) and linolenic acid (≈4%)
as unsaturated fatty acids, and therefore a favorable ratio of
unsaturated to saturated fatty acids of about 78%/22% (21).
Wheat also contains phenolic lipids, known as alkylresorcinols
(1,3-dihydroxybenzene derivatives with an odd-numbered alkyl
chain at position 5 of the benzene ring) that may serve as
markers of whole-grain cereals in food (65) and as biomarkers
of whole-grain wheat intake (66). They have been reported to
prevent colon cancer in mouse and in vitro models based on
their antimutagenic and apoptotic activity (44, 45).
Vitamins and Minerals
Wheat grains are important sources of vitamin E (mainly α-
tocopherol) and B vitamins, especially thiamine (B1), riboflavin
(B2), niacin (B3), pantothenic acid (B5), pyridoxine (B6), and
folates (B9) (Table 1). Whole-grain flours have considerably
higher vitamin contents than white flours because vitamins are
predominantly found in the bran and germ. One important point
to consider related to nutrition is the bioavailability of vitamins.
For example, most of the niacin present in wheat bran is bound,
and only about 10–20% was found to be bioavailable (67).
The major minerals are potassium, phosphorus, magnesium,
and calcium, followed by zinc, manganese, and iron in lower
amounts (Table 1). Copper and selenium are trace minerals.
All vitamins and minerals present in wheat have well-known
functions in supporting growth and in maintaining the health
and well-being of humans.
Phytochemicals
Wheat grains contain small amounts of phytochemicals that
are defined as non-nutritive biologically active molecules
that function in the human body to achieve health benefits,
promote well-being, and prevent certain disease processes.
The two major classes of phytochemicals found in wheat are
phenolic compounds and terpenoids, derived from the shikimate
and mevalonate or methylerythritol phosphate biosynthetic
pathways, respectively (22, 68). Phenolic compounds are a
structurally diverse group comprising phenolic acids (e.g.,
cinnamic acid and benzoic acid derivatives), flavonoids (e.g.,
flavanols and anthocyanins/anthocyanidins), and lignans.
Terpenoids include sterols and stanols, with β-sitosterol as the
primary compound in wheat, that may occur either as free
form, esterified, glycosylated, or acylated and glycosylated. Other
terpenoids are tocopherols and tocotrienols (α-tocopherol is
commonly known as vitamin E) as well as carotenoids that
can be subdivided into oxygen-containing xanthophylls (e.g.,
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lutein and zeaxanthin) and oxygen-free carotenes (e.g., α- and
β-carotene). Depending on their molecular structures, some
carotenes may be converted to vitamin A in humans. With
phytochemicals being mainly located in the aleurone and bran,
they occur in the mg/kg range in whole-grain flours, but with a
wide range of concentrations determined by natural genetic and
environmental variations (69, 70).
Phenolic acids are known as strong antioxidants (71, 72),
and there is evidence that phenolic compounds improve
vascular functions in humans (73) and may have antitumor
activity (44, 74). Considering the low overall concentrations
of phytochemicals in whole-grain flours and absorbance rates
of 5–10% in the human small intestine, direct antioxidant
effects appear to be unlikely. However, the remaining 90–95%
of phytochemicals are transferred to the colon where they are
metabolized by microbiota and may exert positive effects on
colon health through this route.
Wheat Constituents Related to
Consumption
In summary, wheat grains contain low amounts of sugars,
sodium, fat, saturated fatty acids, and are free of cholesterol,
all of them considered to restrict health. As most components
related to health are concentrated in the outer layers (bran)
and germ of the grain, their contents are reduced in flours
with low extraction rates (e.g., white flour), which are used to
make the majority of wheat products (e.g., bread, pasta, and
noodles) consumed in Western countries (Figure 1). Products
made from white flour are usually preferred by consumers
because the high bran content of wholegrain flour may give a
dark color, bitterness, gritty texture, and short shelf life. Changing
consumer preferences is difficult, and thus, whole-grain intake is
still below daily recommendations in most countries. To improve
the situation, research and development should be focused on
combining innovative processing with better product quality
to increase the utilization of whole-grain flours. Moreover,
physicians, nutritionists, and the media should advocate the
consumption of products made from whole grains (75).
Altogether, the consumption of wheat-based foods, especially
whole-grain products, is highly recommended owing to excellent
nutritional profiles and their importance as sources of energy,
proteins, DF, B, and E vitamins, minerals, and different
micronutrients, all contributors to a healthy diet. Depending on
the average annual per capita consumption, wheat contributes
different amounts of nutrients in relation to the overall diet.
The average per capita consumption of wheat worldwide was
67.0 kg (2016–2018), but with considerable regional variations
ranging from 50.4 kg in Africa to 109 kg in Europe, considering
continents, but even ranging from 16.2 kg in Thailand to
209.7 kg in Turkey, considering countries (76). In Germany,
wheat consumption contributes 23% of energy, 34% of digestible
carbohydrates, 34% of protein, 24% of DF, and 20–30% of
vitamins and 10–20% ofminerals compared to the recommended
average intake values (77). However, considering the wide span of
per capita wheat consumption, these values will vary in the same
wide range and the contribution of wheat to dietary nutrient
intake needs to be considered individually for each country.
THE SAD FACE: WHEAT-RELATED
DISORDERS
Immune-mediated adverse reactions to wheat may occur in
predisposed individuals. These hypersensitivities commonly
referred to as wheat-related disorders (WRDs) can be
classified into CD, gluten ataxia, and dermatitis herpetiformis
characterized by an autoimmunogenic response (IgA and IgG
antibodies), into IgE- and non-IgE-mediatedWA and into NCGS
characterized by an innate immune response (78) (Figure 2). A
subgroup of patients with diarrhea-predominant irritable bowel
syndrome may also be affected by wheat consumption.
Celiac Disease
Definition and Prevalence
CD belongs to the most common food-related lifelong disorders
worldwide. It is defined as a chronic immune-mediated small
intestinal enteropathy precipitated by exposure to dietary gluten
in genetically predisposed individuals (7). The term “gluten”
comprises the closely related storage proteins of wheat (gliadins
and glutenins), rye (secalins), and barley (hordeins). No species
or variety of these cereals is currently safe for patients with
CD. Recent epidemiological data suggest a mean worldwide
prevalence of 1.4% [1.1–1.7%] based on positive serology and
of 0.7% [0.5–0.9%] based on biopsy-confirmed diagnosis (79).
The serology-confirmed prevalence values were 1.1% in Africa,
1.3% in Europe and South America, 1.4% in North America
and Oceania, and 1.8% in Asia. Only people from sub-Saharan
Africa appear to be hardly affected. There are considerable
regional differences in seroprevalence ranging as high as 2.1–
8.5% in Algeria, Czech Republic, India, Israel, Mexico, Malaysia,
Saudi Arabia, Sweden, Portugal, and Turkey, or as low as 0.2–
0.8% in Estonia, Germany, Iceland, Libya, Poland, Spain, and
Switzerland. CD can occur at any age, but the biopsy-confirmed
prevalence was significantly greater in children (0.9%) than in
adults (0.5%) and also higher in female (0.6%) compared to male
(0.4%) individuals. The worldwide prevalence of CD increased
from 0.6% [0.5–0.7%] (years 1991–2000) to 0.8% [0.5–1.0%]
(years 2001–2016), but the reasons are still unknown, although
environmental factors are most likely (80).
Causes
A combination of environmental and genetic factors is necessary
to trigger CD in susceptible individuals. Consumption of gluten
from wheat, rye, or barley is the decisive environmental factor
necessary for CD onset. Although comparative data on the CD
activity of single gluten proteins is unavailable, most findings
suggest that all gluten proteins are relevant. The unique structural
features of gluten proteins are long repetitive amino acid
sequences rich in glutamine and proline (62). These sequences
are resistant to human gastrointestinal digestive enzymes, so that
high amounts of long gluten peptides reach the upper small
intestinal mucosa, pass the epithelium, and arrive at the lamina
propria, where CD-specific immune reactions are induced (81).
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FIGURE 1 | Schematic representation of the bread-making process.
FIGURE 2 | Overview of wheat allergy, non-celiac gluten sensitivity, and celiac disease. Abs, antibodies; ATIs, α-amylase/trypsin-inhibitors; HLA, human leukocyte
antigen; Ig, immunoglobulin; NCGS, non-celiac gluten sensitivity.
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Recent evidence suggests that non-gluten proteins, such as
ATIs, may also be involved in fueling the CD-specific immune
response (82, 83).
The genetic susceptibility to develop CD is associated with the
major histocompatibility class II genes on chromosome 6 coding
for human leukocyte antigens (HLA)-DQ2 and -DQ8. HLA-DQ
proteins are heterodimeric receptors expressed on the surface of
antigen-presenting cells (APCs) that are responsible for binding
gluten peptides and presenting them to gluten-specific CD4+ T
cells. Depending on genetic expression patterns, either the HLA-
DQ2.5, -DQ8, or -DQ2.2 heterodimers are present and associated
with a very high, high, or low predisposition for CD, respectively
(84, 85). These different levels of CD risk are due to HLA-DQ2.5
being capable of binding a large repertoire of gluten peptides
that are resistant to gastrointestinal degradation, whereas HLA-
DQ8 and -DQ2.2 bind a small to very small selection of
gluten peptides that are also less resistant to degradation (86).
About 95–97% of CD patients are HLA-DQ2/8 positive, but
this genetic predisposition is also present in about 30% of the
healthy population. Thus, the absence of HLA-DQ2/8 is a reliable
criterion to exclude CD, but its presence is not sufficient to cause
CD. A variety of non-HLA genes, mostly encoding for T cells
or APCs, has been associated with CD development, but each
of these genes most likely only contributes a small percentage
to increase the risk of CD (87). It is interesting to note that
there is a significant correlation between the level of wheat
consumption, the frequency of HLA-DQ2/8 and the prevalence
of CD, but with several outlier populations in regions such
as northwestern India, northern Africa, Mexico, Finland, and
Russia. For example, the prevalence of CD in Algeria is among
the highest worldwide (5.6%), whereas that of Tunisia is very
low (0.3%), although both countries share similar levels of wheat
and barley consumption and frequencies of HLA-DQ2/8 (84).
This discrepancy can only be explained by further environmental
factors that cause a loss of tolerance to dietary gluten and
initiate CD. The most likely factors are infections (rotavirus,
adenovirus 12), changes of intestinal microbiota, increased small
intestinal permeability, and the so-called hygiene hypothesis that
proposed a lower incidence of infections in early childhood as an
explanation for the rise in immune-mediated hypersensitivities
(88). Although childbirth (natural vs. cesarean section), duration
of breastfeeding, and the time of gluten introduction into the
child’s diet have been discussed, the associations are far from
clear, and the cumulative incidence of CD in later childhood
was similar independent of breastfeeding or timing of gluten
introduction (89, 90). Currently, there is no possibility to prevent
CD (91).
Symptoms
The clinical appearance of CD is highly variable and can
range from asymptomatic to full-blown symptoms due to the
multisystemic nature of CD (92). Classical gastrointestinal
symptoms are chronic diarrhea, abdominal pain, vomiting, and
steatorrhea. Extraintestinal manifestations include chronic
fatigue, night blindness, anemia, osteoporosis, thyroid
dysfunction, and reproductive disease (93) and are usually
caused by generalized malabsorption of essential nutrients, e.g.,
vitamins and minerals. Slow growth rates and delayed sexual
maturation are known complications of CD in children and
adolescents. The characteristic feature of CD is damage to the
upper small intestine (duodenal bulb, duodenum, proximal
jejunum) characterized by increased infiltration of intraepithelial
lymphocytes (IELs), crypt hyperplasia, and partial to total villous
atrophy. The degree of mucosal damage is classified according
to Marsh–Oberhuber (into types 0, 1, 2, 3a–c, and 4) (94) or
Corazza (into grades normal, A, B1, and B2) considering the
numbers of IELs per 100 enterocytes, ratio of villous height
to crypt depth, and degree of villous atrophy [overview in
Ludvigsson et al. (7)]. Asymptomatic CD patients have minimal
or no symptoms, but they have increased CD-specific serum
antibody levels and villous atrophy. Potential CD patients have
no symptoms and a normal mucosa, but increased levels of
antibodies indicating an increased risk of developing CD. Most
individuals with asymptomatic or potential CD have not yet been
diagnosed for CD. They may be diagnosed through case-finding
approaches in at-risk populations such as first-degree relatives of
CD patients or patients with autoimmune diseases (e.g., diabetes
mellitus type I, autoimmune hepatitis, autoimmune thyroid
disease) or genetic disorders (e.g., Down syndrome) with known
associations to CD (95–97).
Refractory CD, classified into type I (normal IEL phenotype)
and II (aberrant IEL phenotype), is a rare but very serious
complication, which is characterized by persistence of CD-
specific symptoms and mucosal lesions despite a permanent,
strict gluten-free diet (GFD) (98). Type I can usually be treated
with corticosteroids, but type II imposes a serious risk of
progression to enteropathy-associated T-cell lymphoma, small
intestinal adenocarcinoma, and ulcerative jejunitis.
Diagnosis
The diagnosis of CD requires a high level of clinical suspicion
and a stepwise approach. The diagnostic scheme may consist
of five steps: (a) clinical history and symptoms, (b) serology,
(c) small intestinal histology, (d) response to a GFD, and (e)
HLA status. The most recent diagnostic algorithm developed for
children by the European Society for Pediatric Gastroenterology,
Hepatology, and Nutrition (ESPGHAN) recommends testing
symptomatic patients or risk groups for IgA anti-tissue
transglutaminase antibodies (TGA) and total serum IgA to
exclude IgA deficiency. If IgA TGA is negative and total IgA
is normal, CD is unlikely. If IgA TGA levels are <10 × the
upper limit of normal (ULN), the patient has to undergo upper
endoscopy with multiple biopsies including at least four from
the descending part of the duodenum and at least one from the
duodenal bulb. If IgA TGA levels are >10 × ULN, the patient is
additionally tested for IgA anti-endomysium antibodies (EMAs).
If EMAs are positive, the diagnosis of CD is established, and
a GFD is initiated with subsequent follow-up for improvement
of symptoms and decline of antibodies to substantiate the
correct diagnosis. If EMA is negative, additional testing including
biopsies is needed. Gluten challenge and repetitive biopsies
are only necessary in ambiguous cases. Especially in children,
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biopsies are avoided, if possible, but are still recommended,
if there are uncertainties related to the performance of the
kit used to measure IgA TGA (99). The same algorithm
essentially applies to adults, with the only difference that a
duodenal biopsy is advisable in almost all cases because adults
are more likely to have an alternative diagnosis or to be non-
responsive to a GFD (100). There are many clinical situations
that require special considerations and additional tests, such as
patients under the age of two and patients with selective IgA
deficiency, other immunodeficiencies, or on immunosuppressive
medication (101). In case of potential CD, regular follow-up on a
normal diet is recommended, whereas patients with suspected,
but undocumented CD already adhering to a GFD need to
undergo gluten challenge (102). The final confirmation of CD is
established by a clinical, serological, and histological response to
a strict GFD. Genetic tests based on HLA-DQ2 and -DQ8 alleles
can be used to rule out CD in ambiguous cases because of their
high negative predictive value. The need for mass screening for
CD in the general population is discussed controversially (103).
At present, screening is recommended for close relatives of CD
patients and for persons with diseases known to be associated
with CD such as autoimmune diseases.
Pathomechanism
The pathomechanism of CD is complex and involves both
adaptive and innate immune responses (104). Due to their high
contents of proline and glutamine, gluten proteins are resistant
to complete digestion by human gastrointestinal enzymes. As
a consequence, peptides with a length of nine amino acid
residues and more stay intact and pass the small intestinal
epithelium, either by the trans- or the paracellular routes
into the lamina propria (105). More than 1,000 CD-active
(CD-toxic and/or -immunogenic) gluten peptides derived from
gliadins, glutenins, secalins, hordeins, and avenins have been
identified, seven of which are classified as CD-toxic (tested
in vivo or on organ cultures), five of which are classified as
CD-toxic and CD-immunogenic (tested by T-cell proliferation
assays), and the vast majority of which are classified as CD-
immunogenic (106). Typical features of CD-active peptides
are high contents of proline (P) residues and a left-handed
polyproline II helical conformation that protects from enzymatic
degradation as well as high contents of glutamine (Q) residues
that serve as substrates for deamidation or transamidation by
human tissue transglutaminase (TG2) (107). Having reached
the lamina propria, gluten peptides with QXP or QXXJ motifs
(X, any amino acid, J, hydrophobic amino acid) are specifically
deamidated (Q → E, introduction of a negatively charged
glutamic acid residue) or transamidated by TG2 (either to itself
or to other lysine donors) (108, 109), whereas QP and QXXP
motifs are left unmodified (110). Then, gluten peptides are
bound to the heterodimeric HLA-DQ2 or -DQ8 receptors on
the surface of APCs. Deamidation at positions 4, 6, and 7 of
the gluten peptides strongly favors binding to HLA-DQ2, while
HLA-DQ8 prefers deamidation at positions 1 and 9 (respective
locations of positively charged amino acid residues in the
binding pockets of HLA-DQ2 or -DQ8) (86). APCs subsequently
present gluten peptides to the receptor of naive CD4+ T cells
and promote T-cell activation and differentiation into gluten-
specific inflammatory effector T cells. On the one hand, these
gluten-specific CD4+ T cells secrete proinflammatory cytokines,
such as interferon-γ and tumor necrosis factor (TNF)-α, which
stimulate the release and activation of matrix metallopeptidases.
These break down extracellular matrix proteins and thus
lead to the destruction of the small intestinal epithelium
(proinflammatory Th1-pathway, adaptive immune response).
On the other hand, gluten-specific CD4+ T cells help B cells that
carry internalized TG2-gluten peptide complexes. This results
in B-cell activation and differentiation into plasma cells that
produce IgA and IgG antibodies against gliadin and deamidated
gluten peptides as external antigens, and against endomysium
and TG2 as autoantigens (anti-inflammatory Th2-pathway,
adaptive immune response) (84, 111).
Additionally, gluten peptides stimulate the innate immune
response and trigger the secretion of interleukin (IL)-15
by activating enterocytes, macrophages, and dendritic cells.
As a result, lymphocytes are stimulated to express the
receptor NKG2D and epithelial cells to express MICA (major
histocompatibility complex class I chain-related molecule A), the
ligand for NKG2D. OnceMICA has bound to NKG2D, IELs start
to destroy epithelial cells. The key factor explaining why tolerance
to gluten is lost involving the switch from a tolerogenic Foxp3+
regulatory T-cell response to a proinflammatory Th1 response
still remains elusive (112).
Treatment
A strict GFD with a daily gluten intake below 20mg is currently
the only safe and efficient therapy for CD to fully restore
patient health. Dietetic gluten-free products are made from safe
cereals (e.g., corn, rice, sorghum, or millet), pseudocereals (e.g.,
amaranth, buckwheat, or quinoa), other sources of flour or starch
(potatoes or chestnut), and “gluten replacers” (xanthan or guar
gum) (113). Owing to the restricted availability and high costs of
gluten-free alternatives and their poorer quality (114), many CD
patients regard the GFD as a substantial burden that decreases
quality of life, especially when eating out or traveling. Therefore,
their most pronounced desire is the development of a pill or
a vaccine that will allow them to eat gluten-containing foods,
at least sometimes. Therefore, alternative therapies targeting
different steps in the pathomechanism of CD are in various stages
of development. Therapies that have already reached clinical trial
stage include glucocorticoids (budesonide), oral administration
of gluten-degrading enzymes (ALV003, a mixture of cysteine
endopeptidase B, isoform 2, and a prolyl endopeptidase from
Sphingomonas capsulata), oral intake of gluten-sequestering
polymeric resins [poly(2-hydroxyethylmethacrylate-co-styrene-
4-sulfonic acid, sodium salt)], zonulin antagonists (larazotide
acetate), vaccination (Nexvax2), probiotics, and hookworm
infection (115). All alternative therapies still need to demonstrate
that they are tolerable and safe and have no adverse long-term
side-effects. Especially for gluten-degrading or -removing agents,
the amount of gluten that can be safely ingested needs to be
determined considering all other ingredients of the meal that
may hinder the efficacy of the agent. Finally, the benefits and
risks of alternative therapies have to be carefully weighed against
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the GFD to ensure that CD patients receive the best treatment
option available.
Dermatitis Herpetiformis and Gluten Ataxia
With a prevalence of 0.03–0.07%, dermatitis herpetiformis (DH)
is often referred to as the skin manifestation of CD. Both diseases
are caused by gluten, respond to treatment with a GFD, and share
the genetic predisposition caused by HLA-DQ2 or -DQ8. Typical
symptoms are intense itching and burning papules, macules,
and blisters especially on the elbows, knees, and buttocks. DH
is ideally diagnosed by direct immunofluorescence biopsy of
unaffected skin close to an active lesion that reveals granular
IgA deposits in the papillary dermis. The autoantigen in DH is
epidermal transglutaminase (TG3). The most likely pathogenic
route starts from potential or asymptomatic CD in the small
intestine with secretion of IgA against TG2 and TG3 into the
blood circulation and results in the deposition of TG3 and IgA
against TG3 in the papillary dermis. Due to the presence of
active TG3, IgA–TG3 complexes are formed and crosslinked to
fibrinogen in the skin (116).
Gluten ataxia (GA) can be regarded as rare neurological
manifestation of CD and is defined as idiopathic sporadic
ataxia characterized by the presence of IgA or IgG against
gliadin in the blood. GA presents with gait and lower limb
ataxia, nystagmus, and other visual disorders. Up to 40% of
patients show small intestinal damage as in CD and up to 60%
of patients have evidence of cerebellar atrophy. Much like in
DH, the autoantigen in GA is the primarily brain-expressed
transglutaminase (TG6) and IgA against TG6 are serological
markers for GA. TG6 and IgA against TG6 accumulate in the
brain stem and cerebellum causing infiltration of white matter
with lymphocytes and irreversible loss of Purkinje cells in the
cerebellar cortex. Therefore, a fast diagnosis of GA and treatment
with a GFD are essential to prevent progression of cerebellar
dysfunction (117).
IgE-Mediated Wheat Allergies
WAs are defined as adverse immune responses to wheat proteins
that reproducibly occur in affected individuals within minutes to
hours after exposure (118, 119). A wide variety of wheat proteins
including gluten and non-gluten proteins have been identified as
allergens [overviews in Brouns et al. (120), Juhasz et al. (121),
and Tatham and Shewry (122)]. Depending on the route of
allergen exposure and the underlying pathomechanism,WAs can
be classified into food allergy, wheat-dependent exercise-induced
anaphylaxis (WDEIA), respiratory allergy, and skin allergy. The
prevalence estimates for WAs depend on the assessment method
used, but range from 0.1% (positive food challenge) to 3.6%
(lifetime self-reported prevalence) (123).
Common diagnostic procedures include patient history
reporting reproducible symptoms after allergen exposure, skin
prick tests, analysis of specific IgE antibodies, or functional
assays such as in vitro basophil activation tests and oral food
challenge. While oral food challenge is generally regarded as a
gold standard for the diagnosis of wheat allergy and can offer
clarity in ambiguous cases, it is difficult to undertake in routine
clinical practice and puts patients at risk of experiencing a severe
allergic reaction. The treatment for wheat allergy mostly involves
avoidance of exposure to allergens, either in the form of flours
and flour dust or elimination of wheat products from the diet.
Antihistamines or corticosteroids can be used to treat acute cases
(124, 125).
Themechanism of IgE-mediated allergies includes two phases.
The first step is sensitization to the allergen upon initial contact,
followed by an allergic reaction upon reexposure to the allergen
(126). When an allergen is encountered for the first time, it
is internalized by APCs (e.g., dendritic cells) and presented to
naive CD4+ T cells. In the presence of cytokines, the naive
CD4+ T cells become activated and differentiate into Th2 cells
that subsequently produce different ILs. IL-4 turns on IgE-
producing B cells and sustains the development of Th2 cells, IL-5
activates eosinophils, IL-9 enhances IgE production, mast cell
growth and expression of the high-affinity IgE receptor (FcεRI),
and IL-13 acts on epithelial cells to stimulate mucus secretion.
The secreted IgE antibodies bind to FcεRI on the surface of
mast cells and basophils. When the mast cell carrying IgE
antibodies is reexposed to the allergen, the multivalent allergen
crosslinks two adjacent IgE antibodies and the underlying
FcεRI. This bridging leads to mast cell degranulation with
discharge of primary (preformed) mediators (histamine, neutral
peptidases, acid hydrolases, and proteoglycans such as heparin
and chondroitin sulfate) and synthesis and release of secondary
mediators (leukotrienes, prostaglandin D2, platelet-activating
factor, cytokines, and chemokines). The rapid release of
histamine and leukotrienes is responsible for the intense early
allergic response characterized by wheezing, sneezing, urticaria,
and mucus secretion. The survival of mast cells and enhanced
expression of the FcεRI receptor is sustained by signals from
these receptors, thus providing a mechanism of amplification.
In the following phase, eosinophils are activated by IL-5 and
attracted to the site of the immediate reaction by chemokines
(e.g., eotaxin). By producing cytokines, leukotrienes, and proteins
(major basic protein and eosinophil cationic protein) that are
toxic to epithelial cells, the inflammatory response is amplified
and sustained without additional exposure to the allergen. These
events lead to the late allergic response, which involves further
wheezing, nasal blockage, and eczema. Basophils play a similar
role to that of mast cells, but they circulate in the blood rather
than being present in the affected tissues.
Respiratory and Skin Allergy to Wheat
Respiratory WA comprises baker’s asthma and allergic rhinitis,
which are allergic responses to the inhalation of flours and dust
from wheat and other cereals (rye, barley) known since Roman
times. Both allergies rank among themost prevalent occupational
diseases and affect 1–10% (baker’s asthma) and 18–29% (allergic
rhinitis) of bakers, millers, and confectioners. Depending on the
severity of the reaction, vocational retraining may be necessary.
More than 100 IgE-binding proteins were identified, of which
chloroform–methanol-soluble (CM-) ATIs, lipid transfer (LTP)
and non-specific lipid transfer proteins (nsLTP) are the major
allergens (127).
Contact urticaria is an allergic reaction on the skin following
contact with an eliciting allergen (128). Typical symptoms of
urticaria are localized wheal-and-flare reactions such as hives
and a raised, burning, and/or pruritic swelling of the skin,
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often accompanied by angioedema that appear within 10–30min
after allergen exposure and fade away within hours. In contrast,
contact dermatitis is accompanied by the appearance of large,
burning, and itchy rashes, blisters, and wheals that take several
days to weeks to heal (129). Similar to respiratory WA, millers,
bakers, and flour handlers are most frequently affected.
Food Allergy to Wheat
Wheat is the third most common cause of food allergy
(only surpassed by milk and egg) and has to be labeled on
prepacked foods according to Codex Alimentarius Standard
1–1985 (130) and also non-prepacked foods according to EU
regulation 1169/2011. Wheat food allergy occurs within a few
hours of wheat ingestion and may present with symptoms on
the skin (e.g., atopic dermatitis, urticaria, angioedema), in the
respiratory tract (e.g., wheezing, bronchial obstruction), in the
gastrointestinal tract (e.g., abdominal pain, bloating, diarrhea),
and even anaphylaxis. In comparison to other allergies such as
peanut allergy, the dose of wheat proteins needed to trigger
allergic reactions is usually quite high (about 1 g), but may also
be lower (10mg) depending on individual sensitivities (131).
The causative factors are non-gluten proteins as well as gluten
proteins, with ATIs 0.19, CM1, CM2, CM3, and CM16, LTP,
and nsLTP as well as α-gliadins, γ-gliadins, and HMW-GS as
major allergens (132). The IgE-binding epitopes derived from the
repetitive sequences of gluten proteins such as QFPQQQFPQQ
(ω5-gliadins), QQSFPLQPQQ (ω1,2-gliadins), VQQQQFPGQQ
(α-gliadins), QQLPQPQQP (γ-gliadins), and SQQQPPF (LMW-
GS) with the consensus motif QQX1PX2QQ (with X1 being L, F,
S, or I and X2 being Q, E, or G) are different to those reported for
CD (133).
Wheat-Dependent Exercise-Induced Anaphylaxis
WDEIA is a special form of WA because wheat intake alone
does not trigger the allergic reaction, but in combination with
augmenting cofactors, such as physical exercise. Further cofactors
are alcohol, acetylsalicylic acid (aspirin R©), and other non-
steroidal anti-inflammatory drugs and stress (134, 135). The
estimated prevalence of WDEIA is <0.1%. Clinical features
range from urticaria and angioedema to dyspnea, hypotension,
collapse, and anaphylactic shock. The major triggers are ω5-
gliadins and HMW-GS, but other gluten protein types may also
be involved. A special form of WDEIA is an allergic reaction
caused by epicutaneous sensitization with hydrolyzed wheat
proteins in cosmetics (136). Although WDEIA is regarded as
the best-studied model of cofactor-induced anaphylaxis, it is
still not clear how exactly the cofactors act as adjuvants causing
the reaction. A decreased activation threshold of mast cells and
basophils has been discussed, but it appears to be more likely that
cofactors increase the bioavailability of allergens by promoting
small intestinal permeability (137).
Non-IgE-Mediated Wheat Allergies
Non-IgE-mediated food allergies are well-known in children
under the age of three, and they are divided into three main
clinical conditions: food protein-induced (FPI) enterocolitis
syndrome, FPI proctocolitis, and FPI enteropathies. The
pathomechanism is currently not well-known, but these
conditions are characterized by high levels of IL-13 and TNF-
α as drivers of intestinal epithelial damage and eosinophil
infiltration. The most common trigger for all three conditions
is cow’s milk, but soy, rice, and wheat have also been reported
(138). Non-IgE-mediated food allergies are less well-recognized
in adults (139), but there is an increasing body of evidence
that they may be under-recognized. NCGS might in fact be a
non-IgE-mediated food allergy because of patient history (food
allergy during childhood or presence of atopic diseases) and
serological and histological findings such as positive serum anti-
gliadin antibodies, in vitro basophil activation, and presence of
eosinophils in the intestinal mucosa (140).
Non-Celiac Gluten Sensitivity
NCGS, frequently termed gluten or (non-celiac) wheat
sensitivity, may be defined as a gluten (wheat)-dependent
disorder with symptoms similar to CD, but usually normal small
intestinal mucosa (141). Moreover, NCGS is characterized by
the lack of serum TG2 antibodies and the missing association
to HLA-DQ2/8 alleles. The exact prevalence is still unknown
and may be similar to that of CD with reports ranging from
about 1% in El Salvador (13) and Mexico (11) to 1.7% in Brazil
(10), but may also be higher with up to 6% (142). The clinical
differentiation of NCGS from other WRDs is difficult due to
several common features: similar symptoms, wheat proteins as
the triggering factor, and a GFD as recommended treatment (78).
Typical gastrointestinal manifestations of NCGS are abdominal
pain, bloating, and chronic diarrhea. Frequent extraintestinal
complaints include headache, “foggy mind,” fatigue, anxiety,
depression, numbness in the legs, arms and fingers, and joint
pain (143). In contrast to CD, NCGS is not associated with
malabsorption, nutritional deficiencies, or increased risk for
autoimmune diseases or malignancy.
Because symptoms disappear on a GFD, gluten proteins
have been considered as a precipitating factor (144), but it
is still not clear whether gluten is responsible. Other wheat
constituents such as non-gluten proteins and FODMAPs might
be additionally responsible for NCGS (145). Recent studies
proposed that ATIs contribute to the development of NCGS by
an innate immune response mediated by the toll-like receptor
pathway (146). Due to the absence of NCGS-specific biomarkers,
the diagnosis is currently made by exclusion of CD, WA, other
food intolerances, and irritable bowel syndrome (147). The
diagnosis is definitely proven by oral wheat challenge after at
least 3 weeks on a GFD and the subsequent occurrence of typical
symptoms (148). A GFD is recommended as treatment, whereby
symptoms usually improve rapidly. In contrast to CD, where
strict GFD has to be maintained, patients with NCGS could adapt
a more liberal diet reducing the gluten intake by≈90% (146).
Irritable Bowel Syndrome
Irritable bowel syndrome (IBS) is the most common and
extensively evaluated functional bowel disorder (149). Its
prevalence in adult individuals has been estimated in a range
from 5 to 20%. IBS is not a single disease but rather a
symptom cluster resulting from diverse pathologies (150).
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Typical symptoms, including abdominal discomfort and pain,
gas, bloating, and diarrhea with and without constipation, are
similar to those of CD, NCGS, intestinal bacterial overgrowth,
and lactose intolerance (151). The Rome IV criteria categorize
IBS by the most predominant presenting symptoms: diarrhea,
constipation, mixed, or unspecified (152). The majority of
patients perceive their symptoms as being related to specific
meals, in particular, foods rich in carbohydrates. Wheat is
regarded as one of the most relevant IBS triggers, although
which component of this cereal is involved remains unclear
(153). Gluten, FODMAPs, other wheat proteins, for example,
ATIs, have been suggested as possible factors for symptom
generation. The experimental and clinical evidence on the role
of gluten/wheat in IBS has been presented by Volta et al. (154).
Some types of IBS, especially diarrhea-predominant cases, show
symptomatic improvement on a GFD (155). Today, the diagnosis
is not only based on the exclusion of other food hypersensitivities,
but on positive diagnosis using symptom-related criteria (“Rome
III diagnostic criteria”) (156). The pathomechanism of IBS is not
completely understood; factors important to the development
of IBS include alterations in the gut microbiome, intestinal
permeability, gut immune function, motility, visceral sensation,
brain–gut interactions, and psychosocial status (157). Strategies
for treatment are based on general recommendations such as
avoidance of foods rich in fat and carbohydrates, dairy products,
caffeine, and alcohol, on the one hand, and increased intake of
DF, on the other hand. If patients can associate the ingestion
of certain foods with the complaints, an improvement may be
achieved after restriction of these foods. Diarrhea-predominant
patients are advised to test a GFD for several months (155).
THE SOURCES OF CONFUSION AROUND
THE SAD FACE OF WHEAT
Unsubstantiated Statements Blaming
Wheat
Over the last decade, wheat has been the center of a
vigorous debate related to health and nutrition, and it has
gained an increasingly negative reputation among the Western
population. The first and main source of confusion arose
from several pseudoscientific books such as “Wheat Belly”
(158) and “Grain Brain” (159), numerous media reports and
statements by celebrities promoting the overall impression
that wheat consumption has adverse health effects for the
general population. The main statements claimed that wheat
consumption was the cause of overweight and obesity, that wheat
caused a whole number of other disorders such as diabetes type
2, asthma, reflux disease, sleep disorders, neuronal complaints,
etc., that wheat bread had an overly high glycemic index, that
wheat contained opioids that caused addiction, and that modern
wheat had been genetically modified and contained unique
toxic proteins that caused the higher prevalence of WRDs. In
conclusion, the general population was advised to avoid the
consumption of wheat products.
However, these books intermingle sound scientific evidence
with theoretical, controversial, and wrong statements and make
it virtually impossible for consumers to separate the truth from
myths. The essential summary that “foods made from wheat
make people sick, stupid, fat, and addictive” (158, 159) led
to great uncertainties among consumers. As a consequence,
the popularity of a GFD has increased, with up to 5% of the
population in New Zealand reporting gluten avoidance (160)
and up to 13% of the UK population self-reporting a WRD (9).
The consumption of gluten-free foods has significantly increased
over the last years, up from a global retail sales value of 1.95
× 109 USD in 2012 to 3.84 × 109 USD in 2017, with further
increases projected in the coming years (161). The reasons why
some people voluntarily adopt a GFD include that they think
it might help them reduce weight, that they perceive a GFD as
healthier and better for their overall well-being and that they
self-diagnosed a WRD.
To counteract the increasing uncertainty among consumers,
numerous counterstatements of the scientific community [e.g.,
(120, 162–165)] have emphasized that wheat consumption is
safe for the vast majority of the population and that wheat
avoidance is only necessary after medical diagnosis of a true
WRD. These reviews have compiled convincing evidence to
refute the abovementioned statements and assert that the regular
consumption of whole-grain products is associated with reduced
risks of type 2 diabetes and of colorectal cancer, likely reduced
risks of colon cancer and cardiovascular diseases, and more
favorable weight management (166).
The Increasing Prevalence of
Wheat-Related Disorders
The second source of confusion related to wheat consumption is
based on the increasing amount of evidence from well-founded
epidemiological studies that show a rise in the prevalence of
WRDs over the past 50 years. While this rise can be partially
explained by better diagnostics and improved awareness, recent
reports, e.g., from Denmark (167), Italy (168), the United States
(169), and worldwide (79) show that the prevalence of CD has
indeed increased over time. The same is reported for NCGS (170)
and also for allergies and autoimmune diseases, in general (171).
Despite ongoing research, the underlying causative factors have
not been unambiguously identified so far. WRDs are initiated
through a loss of immunotolerance to wheat proteins at a certain
point in time, but the factors causing this initial loss are the
subject of ongoing investigations and may also be different
depending on the genetic predisposition, dietary habits, and
overall lifestyle of each individual.
The most likely factors include the hygiene hypothesis that
was originally based on the observation that the decreased
frequency of overall infectious and parasitic diseases was
inversely correlated to the increased frequency of allergic and
autoimmune diseases seen in industrialized countries since the
1950s (88). The hygiene hypothesis is supported by studies on
migrants, who are as likely to develop an autoimmune disease
as individuals in the host country with a high incidence of
autoimmune diseases, even if they originally came from a country
with a low incidence of autoimmune diseases, but moved at a
young age (172). Studies in mice support the protective effects
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of pathogenic bacteria, viruses, and parasites on autoimmunity
and the additional positive effects of commensals that stimulate
innate and adaptive immune regulatory pathways (88). In
contrast, a lack of physical activity, a lot of time spent indoors,
and a diet rich in saturated fats and digestible carbohydrates,
but poor in DF, are associated with a loss of microbial diversity
of the gut, skin, and other tissues and a subsequent loss of
symbiotic relationships with parasites and bacteria that used
to exist during human evolution (173–175). Additional factors
contributing to changes in the microbiome are antibiotics and
vaccinations and decreased exposure to airborne bacteria, all of
which may contribute to alterations in intestinal permeability.
Intestinal barrier dysfunction has been associated with a variety
of intestinal and systemic diseases, including CD (176).
Seen from the side of wheat and related cereals, changes
in protein composition due to breeding, heat and cold stress,
or agricultural practices have been postulated as potential
contributors to a higher immunostimulatory potential of modern
wheat species compared to landraces and heritage wheats.
While protein expression patterns do differ between wheat
species, i.e., diploid einkorn, tetraploid emmer, and durum
wheat as well as hexaploid spelt and common wheat (177–
179), there are currently too few comparative in vitro or
in vivo studies available to allow a precise assessment as to
whether these differences might be related to the prevalence
of WRDs or not. For example, the 33-mer peptide from α2-
gliadin that is frequently described as the immunodominant
peptide in CD, was only detected in common wheat and spelt,
but it was not present in emmer, durum wheat, or einkorn
(180). Ancient wheats like einkorn, emmer and spelt were
suggested to provide health benefits compared to common
wheat, but recent reviews collected evidence demonstrating that
they differ little in their composition. Thus, ancient wheats do
not appear to be “healthier” than modern wheats (41), with
some exceptions, e.g., high lutein and steryl ferulate contents in
einkorn (181).
Several comparative studies on old and modern cultivars
within the speciesTriticum aestivum set out to study the influence
of breeding during the last century (182). So far, the results
are somewhat inconclusive because one study from Canada
reported an increase (183), two studies from the United States
essentially reported no change (184, 185), and three others
from the United Kingdom, Germany, and the United States
reported a decrease in protein contents over time (186–188). All
studies report a substantial influence of the growing conditions
on the content and composition of wheat proteins. Regarding
protein composition, an increase in glutenins and a decrease in
gliadins and gliadin/glutenin ratios, but essentially no changes for
albumins/globulins and gluten, were observed in German winter
wheat cultivars from 1891 to 2010, all grown at the same location
in three consecutive years (189). Similar results were reported
by Ozuna and Barro (190). Principal component analysis of the
chromatographic fingerprints of albumins/globulins, gliadins,
and glutenins showed a cluster formation of the most modern
cultivars (first registered from 1981 to 2010) and of the oldest
ones (1891–1920), but with exceptions and samples from
1951 to 1980 in between. The largest variability in protein
FIGURE 3 | Principal component (PC) analysis biplot of protein fingerprints of
albumins/globulins, gliadins, and glutenins relative to the sum of extractable
proteins. The data are displayed for 60 German winter wheat cultivars first
registered from 1891 to 2010 and show the average of three harvest years
(2015–2017). Figure modified from Pronin et al. (191).
profiles was observed for the samples from 1921 to 1950
[Figure 3, (191)]. Altogether, the evidence, so far, points to
the conclusion that old and modern wheat cultivars do show
changes in protein composition due to breeding, but so far,
none of these changes seems to be linked to the prevalence
of WRDs.
As wheat is part of a huge variety of products, the amounts of
immunoreactive proteins in the end-product that is eventually
consumed is more important than in the original flour.
Wheat processing techniques as well as strategies to reduce
exposure have been extensively reviewed recently (165). The
use of ungerminated grains, of refined white flour instead
of wholegrain flour, of fast straight-dough yeast fermentation
instead of diverse and long sourdough fermentations, as well
as the use of wheat gluten as a technofunctional additive
in a number of food products (192) have been discussed as
additional factors that may contribute to causing WRDs (165,
193). Consumption of these wheat products may have increased
the total amount of gluten in the diet, thus surpassing a certain
threshold level necessary to trigger WRDs. However, credible
data about adverse effects of modern wheat processing are
not available, and no epidemiological studies have evaluated
the contribution of modern processing on the increasing
prevalence of WRDs. For example, there is no proof that modern
bread making, including short and non-acidic fermentation
of doughs or addition of vital gluten, resulted in higher
gluten immunoreactivity. Epidemiological data demonstrate
that countries, in which long-fermented sourdough breads
are common (e.g., Finland and Sweden) even have higher
CD prevalences than countries, where short-fermented yeast-
leavened breads are consumed almost exclusively (e.g., Italy and
Spain) (194).
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The Unknowns
The third source of confusion mostly arises from the fact that
the triggers for NCGS and wheat-sensitive IBS have not been
clearly identified, so far (140), partly due to short-comings in
the design of the nutritional intervention studies, placebo and
nocebo effects (195), and/or insufficient characterization of the
wheat product or wheat extract administered. The constituents
that are discussed as causes of NCGS are gluten, non-gluten
proteins (e.g., ATIs), and FODMAPs. In many cases, products
containing wheat flour were used for oral food challenge, and
in this case, gluten, non-gluten proteins, and FODMAPs were
present (196). In other cases, wheat gluten was used, but these
isolates also contain non-gluten proteins, so that the effects
of gluten and ATIs cannot be clearly distinguished (195, 197).
Gluten, as a cause of NCGS, has mostly been inferred from the
fact that NCGS patients’ symptoms are alleviated if they follow
a GFD, but several studies have reported that gluten may not be
the causative factor in NCGS, but rather FODMAPs (195, 198).
ATIs were identified as triggers of innate immunity via the
toll-like receptor 4, and they have been implicated in causing
NCGS (146) and acting as adjuvants of other inflammatory
diseases (78).
Furthermore, there is a significant overlap of symptoms of
CD, NCGS, and IBS. It is clear that CD patients need to
follow a strict GFD, and no positive effects of a GFD or a low
FODMAP diet have been proven for healthy individuals (199).
In between, both NCGS and IBS patients benefit from a low
FODMAP diet, but even more so of a GFD, probably because of a
multifactorial etiology of NCGS that combine a function effect
caused by FODMAPs with a mild immune reaction combined
by a dysbalance of microbiota (200). In most cases, gluten-free
raw materials are naturally low in FODMAPs and also low in
ATIs, so that a GFD is low in all potential causes for NCGS.
In this context, sourdough fermented breads may also be better
tolerated by NCGS and IBS patients, because Lactobacillaceae
and Bifidobacteriaceae, as well as fungi and yeasts, possess
enzymes capable of degrading gluten and FODMAPs (201).
Due to the overlap between a low FODMAP diet and a GFD,
it is likely that patients with NCGS, especially self-diagnosed
ones, are more likely to suffer from IBS. Vice versa, there is
a subgroup of NCGS patients among the IBS patients (140).
A FODMAP-restricted diet is recommended to treat IBS, but
not in the long term, because FODMAPs are also part of DF,
and a complete elimination will have a negative effect on gut
microbial diversity. Further well-designed dietary intervention
studies with appropriate controls and sufficient characterization
of the challenge materials are still needed to identify the causes
of NCGS and also differentiate which patients will benefit from a
GFD or rather a low FODMAP diet.
THE SMILING FACE OF WHEAT PREVAILS
In the last 10 years, wheat has received much negative attention
because several pseudoscientific books and numerous media
reports fueled the overall assumption that wheat consumption
makes people sick. Despite the common consumer perception of
a GFD as being healthy, gluten-free foods had higher contents of
fat, saturated fat, sugar, and salt compared to gluten-containing
foods (202). The most common deficiencies on a GFD are
insufficient amounts of DF, vitamins, calcium, iron, magnesium,
and zinc. Moreover, a strict GFD decisively reduces the quality
of life, as CD patients can confirm, and may lead to low
compliance (203).
Wheat is among the oldest and most extensively grown crops
and one foundation to ensure food security for the increasing
world population. Technological advances in breeding, farming,
and processing have paved the way for wheat to become one of
the most widespread and cheapest raw materials for food and
non-food applications. No other food crop supplies humans with
such a huge diversity of products from bread to other baked
goods and pasta products that serve as staple foods all over the
world. Wheat-based foods provide valuable nutrients such as
proteins, DF, vitamins, minerals, and bioactive phytochemicals
and supply up to 20% of the energy intake of the global
population. Additionally, wheat is important for many non-food
applications, and a number of wheat constituents like starch and
gluten are present in items of daily use. Considering all available
evidence, so far, there is no reason to eliminate wheat from the
diet, except for individuals suffering fromWRDs.
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